We are live on ! Find out more
PGEN icon

Precigen

165 hedge funds and large institutions have $265M invested in Precigen in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 52 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more call options, than puts

Call options by funds: $880K | Put options by funds: $387K

45% more capital invested

Capital invested by funds: $182M → $265M (+$82.8M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 52

2% less funds holding

Funds holding: 169165 (-4)

5.41% less ownership

Funds ownership: 65.46%60.06% (-5.4%)

12% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 25

Holders
165
Holders Change
-4
Holders Change %
-2.37%
% of All Funds
2.84%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
48
Reduced
52
Closed
25
Calls
$880K
Puts
$387K
Net Calls
+$493K
Net Calls Change
+$260K

PGEN Hedge Fund Activity: Q3 2022 in Review

165 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q3 2022, worth a combined $265M — up 45% from $182M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of PGEN and 22 opened new positions — a net loss of 3 holders — while 52 trimmed existing stakes and 48 added.

The largest buyer was Marshall Wace, opening a new position worth an estimated $1.03M. The largest seller was Miller Value Partners, exiting entirely with an estimated $7.5M sold.

  • 165 institutional investors held Precigen (PGEN) as of Q3 2022, down from 169 in Q2 2022.
  • Funds reported $265M of Precigen stock for Q3 2022, up 45% quarter-over-quarter.
  • 22 funds opened new Precigen positions in Q3 2022 and 25 closed out, a net change of -3 holders.
  • The largest Precigen buyer in Q3 2022 was Marshall Wace, an estimated $1.03M added.
  • The largest Precigen seller in Q3 2022 was Miller Value Partners, an estimated $7.5M sold.

Based on aggregated 13F filings for Q3 2022.